To help ensure that patients are treated with the highest quality medical technologies, Aerin Medical protects its intellectual property by securing patents around the world and enforcing those patents when necessary. Aerin’s VivAer® System and RhinAer® System, methods for using both systems, the Aerin® Console, and potential future Aerin products are covered by the U.S. Patents listed below. Aerin also owns issued patents in other countries and additional pending applications worldwide.
U.S. Patents Covering VivAer® System and Method for Nasal Remodeling; Other Nasal Airway Remodeling Techniques and Devices
- 8,936,594
- 8,986,301
- 9,072,597
- 9,179,967
- 9,237,924
- 9,433,463
- 9,486,278
- 9,526,571
- 9,788,886
- 10,398,489
- 10,456,185
- 10,603,059
- D880,694
U.S. Patents Covering RhinAer® System and Method; Treatment of Post-nasal Drip and Chronic Cough; Other Energy-based Treatments of Nasal Airway Tissue, Including Cryotherapy
- 9,072,597
- 9,415,194
- 9,486,278
- 9,801,752
- 9,943,361
- 10,028,780
- 10,335,221
- 10,376,300
- 10,456,186
- 10,631,925
- 10,779,873
- 10,932,853
- 11,033,318
U.S. Patents Covering Aerin Console
U.S. Patents Covering Potential Future Aerin Products and Therapies
- 9,452,010
- 9,687,296
- 9,788,886
- 9,888,957
- 9,913,682
- 10,265,115
- 10,470,814
- 10,722,282
- 10,864,035
- 11,096,738
- 11,116,566
